| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CYRX | Common Stock | Options Exercise | $19K | +8.33K | +1.48% | $2.28* | 572K | Nov 10, 2021 | Direct | F1 |
| transaction | CYRX | Common Stock | Options Exercise | $137K | +56.9K | +9.94% | $2.40* | 629K | Nov 10, 2021 | Direct | F1 |
| transaction | CYRX | Common Stock | Sale | -$828K | -10.6K | -1.69% | $77.97 | 619K | Nov 10, 2021 | Direct | F1, F2 |
| transaction | CYRX | Common Stock | Sale | -$1.78M | -22.6K | -3.65% | $78.73 | 596K | Nov 10, 2021 | Direct | F1, F3 |
| transaction | CYRX | Common Stock | Sale | -$2.01M | -25.2K | -4.22% | $79.81 | 571K | Nov 10, 2021 | Direct | F1, F4 |
| transaction | CYRX | Common Stock | Sale | -$557K | -6.91K | -1.21% | $80.66 | 564K | Nov 10, 2021 | Direct | F1, F5 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CYRX | Option to purchase common stock | Options Exercise | $0 | -8.33K | -100% | $0.00* | 0 | Nov 10, 2021 | Common Stock | 8.33K | $2.28 | Direct | F1, F6 |
| transaction | CYRX | Option to purchase common stock | Options Exercise | $0 | -56.9K | -68.3% | $0.00 | 26.4K | Nov 10, 2021 | Common Stock | 56.9K | $2.40 | Direct | F1, F7 |
| Id | Content |
|---|---|
| F1 | The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2021. |
| F2 | The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.32 to $78.30, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F3 | The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.32 to $79.29, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F4 | The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.32 to $80.31, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F5 | The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.32 to $81.15, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F6 | 1/12 of the options vested on the 22nd of each month for twelve months beginning on 11/22/2012 and ending on 10/22/2013. |
| F7 | 1/6 of the options vested on the 5th of each month for six months beginning on 12/5/2012 and ending on 5/5/2013. |